Atlas Trials

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

Clinical trial NCT05860335 · UNKNOWN

Trial details

NCT number
NCT05860335
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hypopharyngeal Cancer
Start date
2021-07-01
Primary completion
2025-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.